<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>前免疫</title><link/>https://pubmed.ncbi.nlm.nih.gov/?sort=date&amp;term=101560960%20%20%5BNLMID%5D&amp;utm_campaign=journals&amp;v=2。 18.0.post9+e462414＆utm_medium = rss＆ff = 20250319082050＆utm_content = 101560960＆utm_source = chrome＆fc = none<description>前免疫：PubMed的最新结果</description><atom:link href="https://pubmed.ncbi.nlm.nih.gov/?sort=date&amp;term=101560960%20%5BNLMID%5D&amp;utm_campaign=journals&amp;v=2.18.0.post9+e462414&amp;utm_medium=rss&amp;ff=20250319082050&amp;utm_content=101560960&amp;utm_source=Chrome&amp;fc=None" rel="self"></atom:link><docs> http://www.rssboard.org/rss-specification</docs><generator> PubMed RSS提要（2.18.0.post9+E462414）</generator><language> en</language><lastbuilddate>星期三，2025年3月19日12:20:52 +0000</lastbuilddate><pubDate> Wed, 19 Mar 2025 06:00:00 -0400</pubDate><ttl> 120</ttl><item><title> CD19靶向的汽车治疗治疗血液学恶性肿瘤：隐藏的危险是安全的下一个邻居吗？</title><link/> https://pubmed.ncbi.nlm.nih.gov/40103829/？ aign =期刊＆utm_content = 101560960＆fc = none＆ff = 20250319082050＆v = 2.18.0.post9+e462414<description> CD19靶向的嵌合抗原受体（CAR）T细胞疗法在治疗复发和/或难治性B细胞淋巴瘤，B细胞急性淋巴细胞白血病和多发性骨髓瘤的患者方面取得了奇妙的结果。作为一种改变现有治疗范式的新治疗方法，从出现到FDA批准有很短的时间。但是，随着案件数量的增加和时间的流逝，隐藏的问题逐渐暴露出来。在这篇评论中，... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年3月4日； 16：1490491。 doi：10.3389/fimmu.2025.1490491。环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> CD19靶向的嵌合抗原受体（CAR）T细胞疗法在治疗复发和/或难治性B细胞淋巴瘤，B细胞急性淋巴细胞白血病和多发性骨髓瘤的患者方面取得了奇妙的结果。作为一种改变现有治疗范式的新治疗方法，从出现到FDA批准有很短的时间。但是，随着案件数量的增加和时间的流逝，隐藏的问题逐渐暴露出来。 In this review, we summarize the short- and long-term toxicity, such as secondary T-​​cell tumors and lethal CAR tumors, of patients with hematologic malignancies treated with CD19-CAR-T cells, including cytokine release syndrome (CRS), ICANS, and secondary malignancies with low occurrence rates but high mortality, such as secondary T cell tumors and lethal CAR tumors, which may be related to the gene modification目前批准用于CAR-T细胞的病毒载体机制。我们还讨论了旨在提高CAR-T细胞疗法安全性的潜在研究策略。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40103829/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250319082050&v=2.18.0.post9+e462414">40103829</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11914092/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250319082050&v=2.18.0.post9+e462414">PMC11914092</a> | doi： <a href=https://doi.org/10.3389/fimmu.2025.1490491>10.3389/fimmu.2025.1490491</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40103829</guid><pubDate> Wed, 19 Mar 2025 06:00:00 -0400</pubDate><dc:creator> xueshuai ye</dc:creator><dc:creator> Min GE</dc:creator><dc:creator>孟蒂安棕褐色</dc:creator><dc:creator>Yongqiang Wu</dc:creator><dc:creator> Haiqiang Zhang</dc:creator><dc:creator> Zexian Fu</dc:creator><dc:date> 2025-03-19</dc:date><dc:source>免疫学领域</dc:source><dc:title>CD19靶向的汽车治疗治疗血液学恶性肿瘤：隐藏的危险是安全的下一个邻居吗？</dc:title><dc:identifier> PMID：40103829</dc:identifier><dc:identifier> PMC：PMC11914092</dc:identifier><dc:identifier> doi：10.3389/fimmu.2025.1490491</dc:identifier></item><item><title> NK细胞在MDS免疫功能障碍和抗肿瘤研究中的作用进步</title><link/>https://pubmed.ncbi.nlm.nih.gov/40103828/？ aign =期刊＆utm_content = 101560960＆fc = none＆ff = 20250319082050＆v = 2.18.0.post9+e462414<description> MDS是源自造血干细胞的一组异质的髓样肿瘤，具有高度转化为急性髓样白血病（AML）的风险。天然杀伤（NK）细胞对于它们在免疫监测和有效的肿瘤细胞裂解中的作用至关重要，由于MDS中复杂的微环境和细胞因子动力学而导致功能障碍。本文重点介绍了MDS中NK细胞功能障碍的机制以及增强NK细胞活性的最新策略。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年3月4日； 16：1511616。 doi：10.3389/fimmu.2025.1511616。环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> MDS是源自造血干细胞的一组异质的髓样肿瘤，具有高度转化为急性髓样白血病（AML）的风险。天然杀伤（NK）细胞对于它们在免疫监测和有效的肿瘤细胞裂解中的作用至关重要，由于MDS中复杂的微环境和细胞因子动力学而导致功能障碍。本文重点介绍了MDS中NK细胞功能障碍的机制以及增强NK细胞活性以恢复其抗MD疗效的最新策略，从而强调了它们在MDS治疗中的关键作用和潜力。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40103828/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250319082050&v=2.18.0.post9+e462414">40103828</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11913816/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250319082050&v=2.18.0.post9+e462414">PMC11913816</a> | doi： <a href=https://doi.org/10.3389/fimmu.2025.1511616>10.3389/fimmu.2025.1511616</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40103828</guid><pubDate> Wed, 19 Mar 2025 06:00:00 -0400</pubDate><dc:creator>王王</dc:creator><dc:creator>Zuxi Feng</dc:creator><dc:creator> lijuan li</dc:creator><dc:creator> Liansheng Zhang</dc:creator><dc:date> 2025-03-19</dc:date><dc:source>免疫学领域</dc:source><dc:title>NK细胞在MDS免疫功能障碍和抗肿瘤研究中的作用进步</dc:title><dc:identifier>PMID：40103828</dc:identifier><dc:identifier> PMC：PMC11913816</dc:identifier><dc:identifier> doi：10.3389/fimmu.2025.1511616</dc:identifier></item><item><title>头颈癌中新皮子预测算法的比较性能分析</title><link/>https://pubmed.ncbi.nlm.nih.gov/40103827/？ aign =期刊＆utm_content = 101560960＆fc = none＆ff = 20250319082050＆v = 2.18.0.post9+e462414<description>结论：我们的工作强调了IPV与特斯拉在该测定系统中的提高预测能力，并强调需要明确定义哪些实验指标用于评估生物信息学表位预测。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年3月4日； 16：1494453。 doi：10.3389/fimmu.2025.1494453。环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：癌细胞中的突变会导致新肠子的产生，这些新皮细胞可以通过T细胞识别并触发免疫反应。可靠的管道来鉴定给定肿瘤的这种免疫原性的新型新皮肤，将对癌症免疫疗法的设计有益。当前的方法，例如肿瘤新抗原选择联盟（TESLA）提出的管道，旨在选择具有最高可能性的短肽，即MHC-I限制的最小含量。通常，在实验测试时，只有一小部分这些预测的表位被T细胞识别。这尤其有问题，因为急性病的患者可获得的样本量有限，限制了可以在实践中测试的肽数量。这导致我们的小组开发了一条称为识别优先级别效应的内部管道，该管道识别涵盖CD4和CD8表位的长肽。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：在这里，我们系统地比较了与特斯拉管道相比，IPV的性能。<i>在体外与相应的候选肽在体外</i>培养患者外周血单核细胞，并使用细胞因子分泌测定法测量免疫识别。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：IPV管道在预测我们在我们的测定中引起免疫反应的新肠子方面始终优于特斯拉管道。这主要是由于与特斯拉相比，IPV中包含更长的肽。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：我们的工作强调了IPV与特斯拉在该测定系统中的提高预测能力，并强调需要明确定义哪些实验指标用于评估生物信息学表位预测。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40103827/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250319082050&v=2.18.0.post9+e462414">40103827</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11914794/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250319082050&v=2.18.0.post9+e462414">PMC11914794</a> | doi： <a href=https://doi.org/10.3389/fimmu.2025.1494453>10.3389/fimmu.2025.1494453</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40103827</guid><pubDate> Wed, 19 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Leila y Chihab</dc:creator><dc:creator>朱莉·G·伯雷尔（Julie G Burel）</dc:creator><dc:creator>亚伦·米勒（Aaron M Miller）</dc:creator><dc:creator>路易斯·韦斯特伯格（Luise Westernberg）</dc:creator><dc:creator>布兰德·布朗</dc:creator><dc:creator>杰森·格林鲍姆（Jason Greenbaum）</dc:creator><dc:creator>迈克尔·J·科尔（Michael J Korrer）</dc:creator><dc:creator>斯蒂芬·施申伯格（Stephen P Schoenberger）</dc:creator><dc:creator>塞巴斯蒂安·乔伊斯（Sebastian Joyce）</dc:creator><dc:creator>年轻的J金</dc:creator><dc:creator>ZeynepKoşaloğlu-yalçin</dc:creator><dc:creator> Bjoern Peters</dc:creator><dc:date> 2025-03-19</dc:date><dc:source>免疫学领域</dc:source><dc:title>头颈癌中新皮子预测算法的比较性能分析</dc:title><dc:identifier>PMID：40103827</dc:identifier><dc:identifier> PMC：PMC11914794</dc:identifier><dc:identifier> doi：10.3389/fimmu.2025.1494453</dc:identifier></item><item><title>与嗜中性粒细胞细胞外陷阱形成相关的染色质变化全血反映了复杂的免疫信号传导</title><link/>https://pubmed.ncbi.nlm.nih.gov/40103826/？ aign =期刊＆utm_content = 101560960＆fc = none＆ff = 20250319082050＆v = 2.18.0.post9+e462414<description>结论：我们的发现强调了在整个血液环境中研究净形成以捕获中性粒细胞反应和免疫细胞相互作用的复杂性的重要性。这种理解对于确定网络相关炎症性疾病中有效的治疗靶标至关重要。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年3月4日； 16：1515430。 doi：10.3389/fimmu.2025.1515430。环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：中性粒细胞是先天免疫的关键参与者，形成中性粒细胞外陷阱（网）以防御感染。然而，过量的净形成与败血症和免疫骨骼病等炎症条件有关。在孤立的中性粒细胞中研究净形成提供了重要的机械见解，但不能反映全血中免疫相互作用的复杂性，从而限制了我们对中性粒细胞反应的理解。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：这项研究研究了在凤凰12-溶解剂13-乙酸酯（PMA）诱导的全血中的染色质可及性变化，并使用测序（ATAC-SEQ）进行转座酶可访问的染色质（ATAC-SEQ）。我们比较了PMA治疗后，分离和全血的中性粒细胞中的染色质可及性模式，以评估其他免疫细胞和信号环境的影响。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：全血PMA刺激引起了供体之间一致的染色质可及性的变化，证明了净形成过程中有组织的染色质反应。染色质反应的特征是在富含免疫特异性途径的基因组区域的可及性增加，突出了免疫细胞相互作用在净形成中的作用。 PMA诱导后，全血和分离的中性粒细胞中存在差异的可及区域（DAR）显示出与净相关和炎症转录因子的相关性更大，而与孤立的中性粒细胞相关的DARS显示出更少的相关基序。途径分析表明，与孤立的嗜中性粒细胞相比，整个血液反应涉及免疫特异性途径（例如白介素和细胞因子信号传导）的更强激活。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：我们的发现强调了在整个血液环境中研究净形成以捕获中性粒细胞反应和免疫细胞相互作用的复杂性的重要性。这种理解对于确定网络相关炎症性疾病中有效的治疗靶标至关重要。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40103826/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250319082050&v=2.18.0.post9+e462414">40103826</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11914908/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250319082050&v=2.18.0.post9+e462414">PMC11914908</a> | doi： <a href=https://doi.org/10.3389/fimmu.2025.1515430>10.3389/fimmu.2025.1515430</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40103826</guid><pubDate> Wed, 19 Mar 2025 06:00:00 -0400</pubDate><dc:creator>贾斯汀·凯福德（Justin Cayford）</dc:creator><dc:creator>布兰迪·阿特伯里（Brandi Atteberry）</dc:creator><dc:creator> Akanksha Singh-Taylor</dc:creator><dc:creator>安德鲁·凯特（Andrew Retter）</dc:creator><dc:creator>本杰明·P·伯曼（Benjamin P Berman）</dc:creator><dc:creator>特蕾莎·凯利（Theresa K Kelly）</dc:creator><dc:date> 2025-03-19</dc:date><dc:source>免疫学领域</dc:source><dc:title>与嗜中性粒细胞细胞外陷阱形成相关的染色质变化全血反映了复杂的免疫信号传导</dc:title><dc:identifier>PMID：40103826</dc:identifier><dc:identifier> PMC：PMC11914908</dc:identifier><dc:identifier> doi：10.3389/fimmu.2025.1515430</dc:identifier></item><item><title>细胞内HIV-1 TAT调节剂诱导DNA甲基化景观的表观遗传变化</title><link/>https://pubmed.ncbi.nlm.nih.gov/40103825/？ aign =期刊＆utm_content = 101560960＆fc = none＆ff = 20250319082050＆v = 2.18.0.post9+e462414<description>简介：HIV调节蛋白TAT增强了病毒转录并修饰宿主基因表达，影响细胞周期和凋亡等细胞功能。即使在抗逆转录病毒治疗下，在血液和其他组织中也检测到TAT蛋白的残留表达。队列研究表明，尽管有病毒抑制，但患有HIV（PWH）的人仍有增加与慢性炎症，加速免疫老化和细胞衰老有关的合并症的风险，... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年3月4日； 16：1532692。 doi：10.3389/fimmu.2025.1532692。环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">简介：HIV调节蛋白TAT增强了病毒转录并修饰宿主基因表达，影响细胞周期和凋亡等细胞功能。即使在抗逆转录病毒治疗下，在血液和其他组织中也检测到TAT蛋白的残留表达。队列研究表明，尽管有病毒抑制，但患有HIV（PWH）的人仍有增加与慢性炎症，加速免疫衰老和细胞衰老有关的合并症的风险，有时与异常的基因组甲基化模式有关。我们分析了TAT是否影响DNA甲基化并随后影响转录特征，从而导致炎症和加速衰老。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：我们使用全长TAT（TAT101），TAT的第一个外显子（TAT72）或空载体（TETOFF）转染Jurkat细胞。我们通过Infinium甲基化阵列评估了DNA甲基化修饰，并通过RNA-Seq评估了转录组的变化。基因启动子或人体区域中的甲基化水平与其表达数据相关，随后，我们进行了过度代表分析，以识别含有差异甲基化和表达基因的生物学术语。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：TAT101表达在单个CpG位点引起明显的高甲基化变化，从而导致略有全局的DNA高甲基化。基因启动子和身体的甲基化变化导致基因表达改变，特异性调节了Tat101-表达细胞中5.1％差异表达基因（DEG）的基因转录。相反，TAT72对这一表观遗传过程的影响很小。观察到的差异甲基化和表达的基因参与炎症反应，脂质抗原表现和凋亡。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">讨论：HIV感染中的TAT表达可能构成有助于HIV发病机理和慢性炎症的关键表观遗传建模参与者。针对TAT阻滞的临床干预措施可能会减少与HIV感染合并症有关的慢性炎症和细胞衰老。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40103825/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250319082050&v=2.18.0.post9+e462414">40103825</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11913862/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250319082050&v=2.18.0.post9+e462414">PMC11913862</a> | doi： <a href=https://doi.org/10.3389/fimmu.2025.1532692>10.3389/fimmu.2025.1532692</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40103825</guid><pubDate> Wed, 19 Mar 2025 06:00:00 -0400</pubDate><dc:creator> AndreaRodríguez-Agustín</dc:creator><dc:creator> RubénAyala-Suárez</dc:creator><dc:creator> Franciscodíez-fuertes</dc:creator><dc:creator>玛丽亚·何塞·马雷诺（MaríaJoséMaleno）</dc:creator><dc:creator> Izar de Villasante</dc:creator><dc:creator> Angelika Merkel</dc:creator><dc:creator> Mayte Coiras</dc:creator><dc:creator> VíctorCasanova</dc:creator><dc:creator>何塞·阿尔卡米（JoséAlcamí）</dc:creator><dc:creator>努里亚·克莱门特</dc:creator><dc:date>2025-03-19</dc:date><dc:source>免疫学领域</dc:source><dc:title>细胞内HIV-1 TAT调节剂诱导DNA甲基化景观的表观遗传变化</dc:title><dc:identifier>PMID：40103825</dc:identifier><dc:identifier> PMC：PMC11913862</dc:identifier><dc:identifier> doi：10.3389/fimmu.2025.1532692</dc:identifier></item><item><title>肿瘤衍生的细胞外囊泡：乳腺癌免疫调节的主要驱动因素</title><link/>https://pubmed.ncbi.nlm.nih.gov/40103824/？ aign =期刊＆utm_content = 101560960＆fc = none＆ff = 20250319082050＆v = 2.18.0.post9+e462414<description>乳腺癌（BC）仍然是一个重大的全球健康挑战，其特征是其异质性和治疗复杂性。细胞外囊泡（EV）是细胞释放的小膜颗粒，通过转运生物活性分子（例如蛋白质，脂质和核酸）来促进细胞间通信。肿瘤衍生的电动汽车已成为肿瘤微环境（TME）的关键调节剂和BC进展的驱动因素。这些电动汽车携带多种生物活性货物... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年3月4日； 16：1548535。 doi：10.3389/fimmu.2025.1548535。环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">乳腺癌（BC）仍然是一个重大的全球健康挑战，其特征是其异质性和治疗复杂性。细胞外囊泡（EV）是细胞释放的小膜颗粒，通过转运生物活性分子（例如蛋白质，脂质和核酸）来促进细胞间通信。肿瘤衍生的电动汽车已成为肿瘤微环境（TME）的关键调节剂和BC进展的驱动因素。这些电动汽车携带生物活性分子的各种货物，影响了关键过程，例如免疫调节，血管生成和转移。通过改变包括巨噬细胞，树突状细胞和T细胞在内的免疫细胞的行为，肿瘤衍生的EV有助于免疫逃避和肿瘤生长。此外，肿瘤衍生的电动汽车在介导耐药性中发挥了作用，从而影响治疗性干预的有效性。了解卑诗省肿瘤衍生的电动汽车的多面作用对于发展创新的治疗策略至关重要。电动汽车介导的靶向途径有望增强癌症治疗的功效和改善患者预后。这项全面的综述为免疫调节和BC进展中肿瘤衍生的EV的复杂相互作用提供了见解，突出了新型癌症治疗的潜在治疗靶标和途径。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40103824/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250319082050&v=2.18.0.post9+e462414">40103824</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11914124/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250319082050&v=2.18.0.post9+e462414">PMC11914124</a> | doi： <a href=https://doi.org/10.3389/fimmu.2025.1548535>10.3389/fimmu.2025.1548535</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40103824</guid><pubDate> Wed, 19 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Jieming li</dc:creator><dc:creator> shuo yu</dc:creator><dc:creator> Min Rao</dc:creator><dc:creator> Bomin Cheng</dc:creator><dc:date> 2025-03-19</dc:date><dc:source>免疫学领域</dc:source><dc:title>肿瘤衍生的细胞外囊泡：乳腺癌免疫调节的主要驱动因素</dc:title><dc:identifier>PMID：40103824</dc:identifier><dc:identifier> PMC：PMC11914124</dc:identifier><dc:identifier> doi：10.3389/fimmu.2025.1548535</dc:identifier></item><item><title>在尾尾猕猴中，胃肠道感染期间胃肠道中的持续先天免疫功能障碍和ZIKV复制</title><link/>https://pubmed.ncbi.nlm.nih.gov/40103823/？ aign =期刊＆utm_content = 101560960＆fc = none＆ff = 20250319082050＆v = 2.18.0.post9+e462414<description>蚊子传播的黄病毒，包括登革热（DENV）和寨卡病毒（Zikv）病毒，在艾滋病毒率高的地区引起了广泛的流行病，部分原因是节肢动物载体的地理范围扩大。尽管在艾滋病毒率高的地区发生了大量的黄病毒爆发，但对Flavivivirus感染对HIV患者（PLWH）的影响知之甚少。在这里，我们使用hiv/艾滋病的辫子猕猴模型来研究猿猴免疫缺陷病毒的影响... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年3月4日； 16：1535807。 doi：10.3389/fimmu.2025.1535807。环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">蚊子传播的黄病毒，包括登革热（DENV）和寨卡病毒（Zikv）病毒，在艾滋病毒率高的地区引起了广泛的流行病，部分原因是节肢动物载体的地理范围扩大。尽管在艾滋病毒率高的地区发生了大量的黄病毒爆发，但对Flavivivirus感染对HIV患者（PLWH）的影响知之甚少。在这里，我们使用HIV/AIDS的辫子猕猴模型来研究猿猴免疫缺陷病毒（SIV）诱导的免疫抑制对ZIKV复制和发病机理的影响。在急性SIV感染期间，周围ZIKV细胞靶标扩大，先天免疫激活增加。<i>在体外</i>，来自SIV感染的辫子猕猴的外周血单核细胞（PBMC）对ZIKV感染的允许较小。<i>在体内</i>，ZIKV病毒血症被延迟，ZIKV在SIV-ZIKV共感染的动物的胃肠道组织中更加持久。这种持久性与先天细胞（单核细胞，中性粒细胞）募集到血液和组织的变化有关，抗ZIKV免疫降低以及外周炎症和先天免疫基因的持续表达。总的来说，这些发现独特地表明，未处理的SIV感染可能会促进炎症性细胞先天反应，并产生持续的免疫激活状态，这有助于长期ZIKV病毒血症和胃肠道的持久性。此外，这些结果表明，PLWH和其他免疫功能低下的个体可能会延长ZIKV感染的风险更高，从而可能扩大ZIKV传播的窗口。这些见解强调了将PLWH纳入部署疫苗和针对ZIKV治疗的策略的重要性。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40103823/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250319082050&v=2.18.0.post9+e462414">40103823</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11913663/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250319082050&v=2.18.0.post9+e462414">PMC11913663</a> | doi： <a href=https://doi.org/10.3389/fimmu.2025.1535807>10.3389/fimmu.2025.1535807</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40103823</guid><pubDate> Wed, 19 Mar 2025 06:00:00 -0400</pubDate><dc:creator>詹妮弗·蒂森切克（Jennifer Tisoncik-go）</dc:creator><dc:creator>托马斯·B·刘易斯</dc:creator><dc:creator>Leanne S Whitmore</dc:creator><dc:creator>凯瑟琳·沃斯（Kathleen Voss）</dc:creator><dc:creator> Skyler Niemeyer</dc:creator><dc:creator>金戴</dc:creator><dc:creator>保罗·金</dc:creator><dc:creator>Kai Hubbell</dc:creator><dc:creator> Naoto Iwayama</dc:creator><dc:creator>丘尔·艾伦斯（Chul Ahrens）</dc:creator><dc:creator>所罗门·旺加里（Solomon Wangari）</dc:creator><dc:creator>罗伯特·穆纳内（Robert Murnane）</dc:creator><dc:creator> Paul T Edlefsen</dc:creator><dc:creator> Kathryn A Guerriero</dc:creator><dc:creator>迈克尔·盖尔（Michael Gale）</dc:creator><dc:creator> Deborah H Fuller</dc:creator><dc:creator>梅根一个奥康纳</dc:creator><dc:date>2025-03-19</dc:date><dc:source>免疫学领域</dc:source><dc:title>在尾尾猕猴中，胃肠道感染期间胃肠道中的持续先天免疫功能障碍和ZIKV复制</dc:title><dc:identifier>PMID：40103823</dc:identifier><dc:identifier> PMC：PMC11913663</dc:identifier><dc:identifier> doi：10.3389/fimmu.2025.1535807</dc:identifier></item><item><title> &lt;em>; n &lt;/em>;  - 甲状腺肽受体：远不止于化学吸引剂受体。与健康和疾病有关</title><link/>https://pubmed.ncbi.nlm.nih.gov/40103822/？ aign =期刊＆utm_content = 101560960＆fc = none＆ff = 20250319082050＆v = 2.18.0.post9+e462414<description>模式识别受体（PRR）是受体的超家族，可检测病原体和受损细胞的分子结构，并在先天免疫系统的适当功能中起着至关重要的作用。膜结合的PRR的特定亚组由N-甲酰基肽受体（FPRS）表示，这些受体由跨膜G蛋白偶联受体组成，涉及炎症反应。最初在免疫细胞中描述了FPR是... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年3月4日； 16：1568629。 doi：10.3389/fimmu.2025.1568629。环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">模式识别受体（PRR）是受体的超家族，可检测病原体和受损细胞的分子结构，并在先天免疫系统的适当功能中起着至关重要的作用。膜结合的PRR的特定亚组由N-甲酰基肽受体（FPRS）表示，这些受体由跨膜G蛋白偶联受体组成，涉及炎症反应。最初在免疫细胞中描述了FPR，是对组织损伤反应的吞噬细胞中趋化信号的传感器。随后，在包括癌细胞在内的多种细胞类型中也发现了FPR。除了广泛的细胞分布之外，FPR还具有结合具有不同化学和生物学特性的多种配体的能力，从天然肽到合成化合物。 FPR与特定激动剂的结合诱导了一系列功能生物学事件，例如细胞增殖，迁移，血管生成和氧化应激。从所有这些证据中，很明显，FPR是与炎症相关的几种病理生理过程的多方面受体。在这篇综述中，我们提供了FPR的结构功能关系及其在宿主防御中的关键作用的全面分子描述，强调了调节功能在炎症的启动和解决方面。除了在先天免疫反应期间作为PRR的活性外，我们还专注于它们参与病理状况，包括慢性炎症性疾病，神经退行性疾病和癌症，特别强调了FPR作为精度医学时代的有前途的治疗策略。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40103822/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250319082050&v=2.18.0.post9+e462414">40103822</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11913705/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250319082050&v=2.18.0.post9+e462414">PMC11913705</a> | doi： <a href=https://doi.org/10.3389/fimmu.2025.1568629>10.3389/fimmu.2025.1568629</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40103822</guid><pubDate> Wed, 19 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Filomena napolitano</dc:creator><dc:creator> Nunzia Montuori</dc:creator><dc:date> 2025-03-19</dc:date><dc:source>免疫学领域</dc:source><dc:title>&lt;em>; n &lt;/em>;  - 甲状腺肽受体：远不止于化学吸引剂受体。与健康和疾病有关</dc:title><dc:identifier>PMID：40103822</dc:identifier><dc:identifier> PMC：PMC11913705</dc:identifier><dc:identifier> doi：10.3389/fimmu.2025.1568629</dc:identifier></item><item><title>氨基酸与胃食管反流疾病之间的关系：孟德尔随机分析的证据与荟萃分析结合</title><link/>https://pubmed.ncbi.nlm.nih.gov/40103821/?utm_source = chrome&amp;utm_medium = rsss＆utm_camp aign =期刊＆utm_content = 101560960＆fc = none＆ff = 20250319082050＆v = 2.18.0.post9+e462414<description>结论：谷氨酸可能通过影响神经系统和促进炎症反应等机制来增加胃食管反流疾病的风险并加剧。深入研究谷氨酸在胃食管反流疾病中的作用丰富了我们对疾病生物学机制的理解，并可能为临床治疗和营养管理提供新的策略。这种见解可以帮助制定更健康的饮食计划，从而受益... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年3月4日； 16：1420132。 doi：10.3389/fimmu.2025.1420132。环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：全球流行的胃肠道疾病，胃食管反流疾病（GERD）在整个地区都表现出可变的患病率，在西方国家和亚洲国家中观察到较高的频率。关键因素包括不健康的饮食模式，烟草的使用，酒精的消费，多余的体重和肥胖，以及妊娠和糖尿病等健康状况。常见的表现包括胃灼热和胸骨后面的燃烧不适，如果没有适当的治疗，可以发展到更严重的问题，例如食管炎和巴雷特的食管。当认为必要时，管理和预防方法主要涉及生活方式，药物治疗和手术干预措施的修改。利用Omics Mendelian随机化（OMR）来研究遗传变异和疾病之间的致病联系，为胃食管反流疾病的生物基础提供了见解。它有助于确定治疗的新目标。氨基酸在胃食管反流疾病中的影响表明了复杂性，具有减轻和加剧症状的潜力，强调了个性化营养和治疗策略的重要性。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：这项研究基于Omics Mendelian随机化方法，再加上荟萃分析技术，以增强研究结果的精度。此外，实施了反向验证程序，以进一步验证积极发现与疾病结果之间的关联。在整个研究中，采取了多项校正措施来确保结果的准确性和可靠性。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：根据我们的研究方法，我们最终发现谷氨酸加剧了胃食管反流疾病，从而增加了其风险。支持此支持的数据包括对芬兰数据库的20种氨基酸和结果的分析，该数据库表明，谷氨酸的胃食管反流疾病风险的优势比（OR）为1.175（95％置信区间（CI）：1.000〜1.380，p = 0.05），和0.161的Beta值。英国数据库结果的分析表明，谷氨酸的胃食管反流病风险为1.399（95％CI：1.060〜1.847，p = 0.018），β值为0.336。在对MR结果进行荟萃分析并应用多次校正之后，胃食管反流疾病风险的合并或谷氨酸的合并或谷氨酸为1.227（95％CI：1.068〜1.411 P = 0.043）;三个主要MR结果的β值在方向上是一致的。在积极结果的基础上，来自两个不同数据库源的谷氨酸数据库源的反向验证显示：在Finngen数据库中，胃食管反流疾病作为暴露，逆差异加权（IVW）方法导致p值为0.059;在同一条件下的IEU数据库中，IVW P值为1.433。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：谷氨酸可能通过影响神经系统和促进炎症反应等机制来增加胃食管反流疾病的风险并加剧。深入研究谷氨酸在胃食管反流疾病中的作用丰富了我们对疾病生物学机制的理解，并可能为临床治疗和营养管理提供新的策略。这种见解可以帮助制定更健康的饮食计划，从而使患者受益。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40103821/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250319082050&v=2.18.0.post9+e462414">40103821</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11914792/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250319082050&v=2.18.0.post9+e462414">PMC11914792</a> | doi： <a href=https://doi.org/10.3389/fimmu.2025.1420132>10.3389/fimmu.2025.1420132</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40103821</guid><pubDate> Wed, 19 Mar 2025 06:00:00 -0400</pubDate><dc:creator>江恩</dc:creator><dc:creator>YongQing Guo</dc:creator><dc:creator> Rui Cao</dc:creator><dc:date> 2025-03-19</dc:date><dc:source>免疫学领域</dc:source><dc:title>氨基酸与胃食管反流疾病之间的关系：孟德尔随机分析的证据与荟萃分析结合</dc:title><dc:identifier>PMID：40103821</dc:identifier><dc:identifier> PMC：PMC11914792</dc:identifier><dc:identifier> doi：10.3389/fimmu.2025.1420132</dc:identifier></item><item><title>肾小球疾病的炎症</title><link/>https://pubmed.ncbi.nlm.nih.gov/40103820/？ aign =期刊＆utm_content = 101560960＆fc = none＆ff = 20250319082050＆v = 2.18.0.post9+e462414<description>肾小球细胞的结构和功能完整性对于维持正常肾功能至关重要。肾小球疾病涉及对肾脏的慢性组织学损害，与肾小球细胞（如内皮细胞，膜细胞）（MCS）和足细胞的损伤有关。当面对致病条件时，这些细胞释放促炎性细胞因子，例如趋化因子，炎症因子和粘附因子。这些物质与肾小球细胞相互作用... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年3月4日； 16：1526285。 doi：10.3389/fimmu.2025.1526285。环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">肾小球细胞的结构和功能完整性对于维持正常肾功能至关重要。肾小球疾病涉及对肾脏的慢性组织学损害，与肾小球细胞（如内皮细胞，膜细胞）（MCS）和足细胞的损伤有关。当面对致病条件时，这些细胞释放促炎性细胞因子，例如趋化因子，炎症因子和粘附因子。这些物质通过特定的炎症途径与肾小球细胞相互作用，从而损害了肾小球的结构和功能，最终导致肾小球疾病。尽管炎症在慢性肾脏疾病中的作用是众所周知的，但导致肾小球疾病的特定分子途径在很大程度上仍然不清楚。长期以来，人们相信只有免疫细胞才能分泌炎症因素。因此，针对免疫细胞的靶向疗法被认为是治疗肾小球疾病炎症的首选。但是，新兴的研究表明，非免疫细胞（例如肾小球内皮细胞，MCS和足细胞）也可以通过释放炎症因子来在肾脏炎症中发挥作用。同样，应考虑针对肾小球细胞的靶向疗法。这篇综述旨在发现与肾小球炎症的炎症和途径有关的肾小球疾病，并首次总结说，肾小球中的非免疫细胞可以通过分泌炎症因素来参与肾小球炎症性损害，从而为未来的策略提供预防和治疗肾小球疾病的有价值参考。更重要的是，我们强调了靶向的肾小球细胞疗法，这可能是未来治疗肾小球疾病的关键方向。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40103820/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250319082050&v=2.18.0.post9+e462414">40103820</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11913671/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250319082050&v=2.18.0.post9+e462414">PMC11913671</a> | doi： <a href=https://doi.org/10.3389/fimmu.2025.1526285>10.3389/fimmu.2025.1526285</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40103820</guid><pubDate> Wed, 19 Mar 2025 06:00:00 -0400</pubDate><dc:creator> YongQing Xiong</dc:creator><dc:creator>韦李</dc:creator><dc:creator>Songzhi Jin</dc:creator><dc:creator> Shujing Wan</dc:creator><dc:creator> Suzhen Wu</dc:creator><dc:date> 2025-03-19</dc:date><dc:source>免疫学领域</dc:source><dc:title>肾小球疾病的炎症</dc:title><dc:identifier>PMID：40103820</dc:identifier><dc:identifier> PMC：PMC11913671</dc:identifier><dc:identifier> doi：10.3389/fimmu.2025.1526285</dc:identifier></item><item><title>病例报告：免疫疗法引起的皮肤结节病的免疫结构类似于腹膜炎症</title><link/>https://pubmed.ncbi.nlm.nih.gov/40103819/？ aign =期刊＆utm_content = 101560960＆fc = none＆ff = 20250319082050＆v = 2.18.0.post9+e462414<description> AVELUMAB是抗PD-L1免疫检查点抑制剂（ICI）。像其他ICI一样，AVELUMAB可能会引起与免疫相关的不良事件。尽管很少见，但在抗CTLA-4和抗PD-1免疫疗法的患者中已经描述了类似类似的肉芽肿反应。在这里，我们报告了接受转移性结肠癌avelumab的患者中出现的皮肤皮肤病的病例。一名56岁的非洲裔美国妇女患有转移性结肠癌，经过多行... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年3月3日； 16：1432927。 doi：10.3389/fimmu.2025.1432927。环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> AVELUMAB是抗PD-L1免疫检查点抑制剂（ICI）。像其他ICI一样，AVELUMAB可能会引起与免疫相关的不良事件。尽管很少见，但在抗CTLA-4和抗PD-1免疫疗法的患者中已经描述了类似类似的肉芽肿反应。在这里，我们报告了接受转移性结肠癌avelumab的患者中出现的皮肤皮肤病的病例。一名56岁的非洲裔美国妇女患有转移性结肠癌，在包括其他免疫疗法在内的多种治疗后进展，已与AVELUMAB进行了临床试验。治疗期间，患者患有两个皮肤病变，对两次活检的组织病理学检查表明，在真皮中，慢性肉芽肿性炎症与含有小行星体的多核巨细胞，与皮肤结节病一致。多重免疫荧光揭示了患者皮肤结节病变的免疫结构与切除的肿瘤转移之间的相似之处。 Recognizing cutaneous sarcoidosis as a rare adverse effect of ICI immunotherapy is important because sarcoidal lesions can be mistaken for metastatic disease on clinical exam and medical imaging. We noticed similar immune composition of the sarcoidal granuloma and tumor microenvironment. However, further studies are needed to fully elucidate the mechanism of ICI associated sarcoidosis.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40103819/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250319082050&v=2.18.0.post9+e462414">40103819</a> | PMC: <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11914793/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250319082050&v=2.18.0.post9+e462414">PMC11914793</a> | DOI: <a href=https://doi.org/10.3389/fimmu.2025.1432927>10.3389/fimmu.2025.1432927</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:40103819</guid><pubDate> Wed, 19 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Catherine J Wang</dc:creator><dc:creator> Jennifer Strong</dc:creator><dc:creator> Margaret E Gatti-Mays</dc:creator><dc:creator> Wiem Lassoued</dc:creator><dc:creator> Sam Sater</dc:creator><dc:creator>朱利叶斯·施特劳斯</dc:creator><dc:creator>Jason M Redman</dc:creator><dc:creator> Jeffrey Schlom</dc:creator><dc:creator> James L Gulley</dc:creator><dc:creator> Isaac Brownell</dc:creator><dc:date> 2025-03-19</dc:date><dc:source>免疫学领域</dc:source><dc:title>Case Report: The immune architecture of immunotherapy-induced cutaneous sarcoidosis resembles peritumoral inflammation</dc:title><dc:identifier> pmid:40103819</dc:identifier><dc:identifier> pmc:PMC11914793</dc:identifier><dc:identifier> doi:10.3389/fimmu.2025.1432927</dc:identifier></item><item><title> Technological breakthroughs and advancements in the application of mRNA vaccines: a comprehensive exploration and future prospects</title><link/> https://pubmed.ncbi.nlm.nih.gov/40103818/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=101560960&amp;fc=None&amp;ff=20250319082050&amp;v=2.18.0.post9+e462414<description> mRNA vaccines utilize single-stranded linear DNA as a template for in vitro transcription. The mRNA is introduced into the cytoplasm via the corresponding delivery system to express the target protein, which then performs its relevant biological function. mRNA vaccines are beneficial in various fields, including cancer vaccines, infectious disease vaccines, protein replacement therapy, and treatment of rare diseases. They offer advantages such as a simple manufacturing process, a quick... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025 Mar 4;16:1524317. doi: 10.3389/fimmu.2025.1524317.环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> mRNA vaccines utilize single-stranded linear DNA as a template for <i>in vitro</i> transcription. The mRNA is introduced into the cytoplasm via the corresponding delivery system to express the target protein, which then performs its relevant biological function. mRNA vaccines are beneficial in various fields, including cancer vaccines, infectious disease vaccines, protein replacement therapy, and treatment of rare diseases. They offer advantages such as a simple manufacturing process, a quick development cycle, and ease of industrialization. Additionally, mRNA vaccines afford flexibility in adjusting antigen designs and combining sequences of multiple variants, thereby addressing the issue of frequent mutations in pathogenic microorganisms. This paper aims to provide an extensive review of the global development and current research status of mRNA vaccines, with a focus on immunogenicity, classification, design, delivery vector development, stability, and biomedical application. Moreover, the study highlights current challenges and offers insights into future directions for development.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40103818/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250319082050&v=2.18.0.post9+e462414">40103818</a> | PMC: <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11913674/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250319082050&v=2.18.0.post9+e462414">PMC11913674</a> | DOI: <a href=https://doi.org/10.3389/fimmu.2025.1524317>10.3389/fimmu.2025.1524317</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:40103818</guid><pubDate> Wed, 19 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Zhimeng Wei</dc:creator><dc:creator> Shuai Zhang</dc:creator><dc:creator> Xingya Wang</dc:creator><dc:creator> Ying Xue</dc:creator><dc:creator> Sheng Dang</dc:creator><dc:creator> Jingbo Zhai</dc:creator><dc:date> 2025-03-19</dc:date><dc:source>免疫学领域</dc:source><dc:title>Technological breakthroughs and advancements in the application of mRNA vaccines: a comprehensive exploration and future prospects</dc:title><dc:identifier> pmid:40103818</dc:identifier><dc:identifier> pmc:PMC11913674</dc:identifier><dc:identifier> doi:10.3389/fimmu.2025.1524317</dc:identifier></item><item><title> Gamma-irradiated fowl cholera vaccines formulated with different adjuvants induced antibody response and cytokine expression in chickens</title><link/> https://pubmed.ncbi.nlm.nih.gov/40103817/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=101560960&amp;fc=None&amp;ff=20250319082050&amp;v=2.18.0.post9+e462414<description> Fowl cholera is one of the most serious and economically important infectious diseases of poultry caused by Pasteurella multocida. Formalin-inactivated vaccine, administered intramuscularly, is widely used in Ethiopia with a low success rate. Gamma irradiation is an effective approach to inactivate pathogens for vaccine development. In a previous study, we reported the feasibility of developing gamma-irradiated vaccines that induced both systemic and mucosal antibody responses with complete... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025 Feb 27;16:1513443. doi: 10.3389/fimmu.2025.1513443.环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> Fowl cholera is one of the most serious and economically important infectious diseases of poultry caused by <i>Pasteurella multocida</i> . Formalin-inactivated vaccine, administered intramuscularly, is widely used in Ethiopia with a low success rate. Gamma irradiation is an effective approach to inactivate pathogens for vaccine development. In a previous study, we reported the feasibility of developing gamma-irradiated vaccines that induced both systemic and mucosal antibody responses with complete protection against homologous lethal challenge. In the present study, we aimed to broaden our understanding of the immunogenicity of the gamma-irradiated vaccines by including peripheral blood mononuclear cells (PBMC) response analysis. A total of 156 eight-week-old fowl cholera-specific antibody negative Bovans Brown chickens were utilized in this experiment. The performances of gamma-irradiated <i>P. multocida</i> vaccines formulated with different adjuvants, Montanide Gel 01 PR (G-1), Carbigen <sup>®</sup> (G-2), Emulsigen-D <sup>®</sup> +aluminum hydroxide gel (G-3), and Emulsigen-p <sup>®</sup> (G-4) were evaluated in comparison with the formalin-inactivated vaccine (G-5) and unvaccinated control (G-6). Chickens received two doses of the vaccines at days 0 and 21. Sera, tracheal, and crop lavage were collected at days 0, 21, 35, and 56 to assess IgG and IgA levels using indirect and sandwich ELISA, respectively. PBMC proliferation was compared between vaccinated and unvaccinated controls. In addition, vaccination-induced expression of cytokine genes was analyzed in PBMC using qPCR. Chickens were challenged with 2.5x10 <sup>7</sup> CFU/ml of <i>P. multocida</i> biotype A intramuscularly one day after day-56 sampling. Significant serum IgG titers were detected three weeks after primary vaccination in G1, G3, and G5. IgG titer substantially increased in all vaccinated groups two weeks post-booster dose. IgA response was induced by gamma-irradiated vaccines but not formalin-inactivated vaccines. Only PBMC from vaccinated chickens proliferated in response to re-stimulation with <i>P. multocida</i> antigen, indicating vaccine-specific priming. Interestingly, gamma-irradiated vaccines resulted in a higher fold change in mRNA transcripts of IFN-γ (>;1000-fold change) IL-6 (>;500-fold change), and IL-12p40 (>;200-fold change), which are hallmarks of a Th1 dominant response, which is essential to combat intracellular infection. Lastly, the candidate vaccines demonstrated various levels of protection, with Emulsigen-D <sup>®</sup> containing vaccine rendering complete protection against homologous lethal challenge. In conclusion, gamma-irradiated vaccines can induce broad immune responses, humoral and cellular, and protect against severe outcome of fowl cholera. Therefore, this study has contributed to growing knowledge on the immunogenicity and efficacy of gamma-irradiated vaccines and has shown the potential of such a vaccine platform for field application in extensive as well as intensive farm settings.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40103817/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250319082050&v=2.18.0.post9+e462414">40103817</a> | PMC: <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11914910/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250319082050&v=2.18.0.post9+e462414">PMC11914910</a> | DOI: <a href=https://doi.org/10.3389/fimmu.2025.1513443>10.3389/fimmu.2025.1513443</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:40103817</guid><pubDate> Wed, 19 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Eyerusalem Belay</dc:creator><dc:creator> Molalegne Bitew</dc:creator><dc:creator> Saddam Mohammed Ibrahim</dc:creator><dc:creator> Bereket Dessalegn</dc:creator><dc:creator> Solomon Lulie Abey</dc:creator><dc:creator> Haileyesus Dejene</dc:creator><dc:creator> Mastewal Birhan</dc:creator><dc:creator> Dawit Duffera</dc:creator><dc:creator> Eyob Asefa</dc:creator><dc:creator> Liyuwork Tesfaw</dc:creator><dc:creator> Takele Abayneh</dc:creator><dc:creator> Kedir Sherefa</dc:creator><dc:creator> Wubet W/Medhin</dc:creator><dc:creator> Yeneneh Tesfaye</dc:creator><dc:creator> Keyru Tuki</dc:creator><dc:creator> Esayas Gelaye</dc:creator><dc:creator> Richard Thiga Kangethe</dc:creator><dc:creator> Viskam Wijewardana</dc:creator><dc:creator> Carla Bravo De Rueda</dc:creator><dc:date> 2025-03-19</dc:date><dc:source>免疫学领域</dc:source><dc:title>Gamma-irradiated fowl cholera vaccines formulated with different adjuvants induced antibody response and cytokine expression in chickens</dc:title><dc:identifier> pmid:40103817</dc:identifier><dc:identifier> pmc:PMC11914910</dc:identifier><dc:identifier> doi:10.3389/fimmu.2025.1513443</dc:identifier></item><item><title> Advance in chimeric antigen receptor T therapy in autoimmune diseases</title><link/> https://pubmed.ncbi.nlm.nih.gov/40103816/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=101560960&amp;fc=None&amp;ff=20250319082050&amp;v=2.18.0.post9+e462414<description> Autoimmune diseases are a group of diseases in which the body&#39;s immune system misrecognizes its own antigens resulting in an abnormal immune response, which can lead to pathological damage to or abnormal functioning of its own tissues. Current treatments are mainly hormones and broad-spectrum immunosuppressants, but these can lead to a decline in the patient&#39;s immunity. Chimeric antigen receptor T (CAR-T) Cell therapy has emerged, and now the structure of CAR has changed from first generation to... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025 Mar 4;16:1533254. doi: 10.3389/fimmu.2025.1533254.环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> Autoimmune diseases are a group of diseases in which the body&#39;s immune system misrecognizes its own antigens resulting in an abnormal immune response, which can lead to pathological damage to or abnormal functioning of its own tissues. Current treatments are mainly hormones and broad-spectrum immunosuppressants, but these can lead to a decline in the patient&#39;s immunity. Chimeric antigen receptor T (CAR-T) Cell therapy has emerged, and now the structure of CAR has changed from first generation to fourth generation of CAR. The significant achievement of CAR-T therapy to B-cell leukemia has also inspired the treatment of autoimmune diseases, and by investigating the mechanisms of different autoimmune diseases, different designs of CAR-T can be used to specifically treat autoimmune diseases. In this review, we will discuss the therapeutic strategies of CAR-T cells in different autoimmune diseases and the limitations of the treatment.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40103816/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250319082050&v=2.18.0.post9+e462414">40103816</a> | PMC: <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11913860/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250319082050&v=2.18.0.post9+e462414">PMC11913860</a> | DOI: <a href=https://doi.org/10.3389/fimmu.2025.1533254>10.3389/fimmu.2025.1533254</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:40103816</guid><pubDate> Wed, 19 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Xiaolan Ji</dc:creator><dc:creator> Yunfan Sun</dc:creator><dc:creator> Yuyang Xie</dc:creator><dc:creator> Jianling Gao</dc:creator><dc:creator>智张</dc:creator><dc:date>2025-03-19</dc:date><dc:source>免疫学领域</dc:source><dc:title>Advance in chimeric antigen receptor T therapy in autoimmune diseases</dc:title><dc:identifier> pmid:40103816</dc:identifier><dc:identifier> pmc:PMC11913860</dc:identifier><dc:identifier> doi:10.3389/fimmu.2025.1533254</dc:identifier></item><item><title> Multifaceted, unique role of CD11c in leukocyte biology</title><link/> https://pubmed.ncbi.nlm.nih.gov/40103815/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=101560960&amp;fc=None&amp;ff=20250319082050&amp;v=2.18.0.post9+e462414<description> CD11c is widely known as a dendritic cell surface marker but its non-dendritic cell expression profiles as well as its functional role have been gradually delineated. As a member of leukocyte-specific β2 integrin family, CD11c forms a heterodimer with CD18. CD11c/CD18 takes different conformations, which dictate its ligand binding. Here we reviewed CD11c current state of art, in comparison to its sister proteins CD11a, CD11b, and CD11d, illustrating its unique feature in leukocyte biology. </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025 Mar 4;16:1556992. doi: 10.3389/fimmu.2025.1556992.环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> CD11c is widely known as a dendritic cell surface marker but its non-dendritic cell expression profiles as well as its functional role have been gradually delineated. As a member of leukocyte-specific β2 integrin family, CD11c forms a heterodimer with CD18. CD11c/CD18 takes different conformations, which dictate its ligand binding. Here we reviewed CD11c current state of art, in comparison to its sister proteins CD11a, CD11b, and CD11d, illustrating its unique feature in leukocyte biology.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40103815/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250319082050&v=2.18.0.post9+e462414">40103815</a> | PMC: <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11913667/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250319082050&v=2.18.0.post9+e462414">PMC11913667</a> | DOI: <a href=https://doi.org/10.3389/fimmu.2025.1556992>10.3389/fimmu.2025.1556992</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:40103815</guid><pubDate> Wed, 19 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Lifei Hou</dc:creator><dc:creator> Sophia Koutsogiannaki</dc:creator><dc:creator> Koichi Yuki</dc:creator><dc:date> 2025-03-19</dc:date><dc:source>免疫学领域</dc:source><dc:title>Multifaceted, unique role of CD11c in leukocyte biology</dc:title><dc:identifier> pmid:40103815</dc:identifier><dc:identifier> pmc:PMC11913667</dc:identifier><dc:identifier> doi:10.3389/fimmu.2025.1556992</dc:identifier></item></channel></rss>